Market Insights
New Hope for Bradycardia: Nanobody Agonist NB5 Elevates Pacing Rate in Human Cardiomyocytes
A recent Nature Communications study reports a breakthrough nanobody NB5 that specifically binds and activates the HCN4 channel extracellularly. It of...
